Date: 2017-03-06
Type of information: Nomination
Compound:
Company: Polyphor (Switzerland)
Therapeutic area: Infectious diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On March 6, 2017, Polyphor has announced the appointment of Dr. Debra Barker to the role of Chief Medical and Development Officer (CMDO). Dr. Barker joins Polyphor effective May 01, 2017. Dr. Barker joins from Novartis, where she currently is Global Head of Medical Affairs for the
Ophthalmology business. Previously, she covered several important positions in Novartis including Development Head for Infectious Diseases, Transplants and Immunology, Global Head of Clinical Operations and Services, and several senior roles in Respiratory, Oncology Biosimilars and Dermatology. Dr. Barker previously worked for Roche, Smithkline Beecham and Knoll in Clinical and Commercial roles. She worked on anti-infectives for several years and brings extensive experience in the design and implementation of clinical studies including pivotal trials, in the interaction with regulatory bodies and in establishing relationships with key opinion leaders.
- Dr. Barker succeeds Leon Hooftman who leaves Polyphor to take a new position.
Financial terms:
Latest news:
Is general: Yes
